2Gentile A,Bardach A,Ciapponi A,et al.Epidemiology ofcommunity-acquired pneumonia in children of Latin Americaand the Caribbean:a systematic review and meta-analysis.IntJ Infect Dis,2012,16(1):e5-15.
3Bébéar C,Pereyre S,Peuchant O.Mycoplasma pneumoniae:susceptibility and resistance to antibiotics.Future Microbiol,2011,6(4):423-431.
5Matsuoka M,Narita M,Okazaki N,et al.Characterizationand molecular analysis of macrolide-resistant Mycoplasmapneumoniae clinical isolates obtained in Japan.Antimicrob A-gents Chemother,2004,48(12):4624-4630.
6Matsuoka M,Narita MtOkazaki N,et al. Characterization and molecularanalysis of macrolide-resistant Mycoplasma pneumoniae clinical isolatesobtained in Japan [ J] . Antitnicrob Agents CKemother, 2004,48 ( 12 ):4624 - 4630.
7Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukot-riene receptor antagonist zafirlucast in subjects with cough-variant asthma[J].J Asthma,2002,39(4) :291 -297.
